Table 2 The associations of ApoA1, ApoB levels and ApoB/A1 ratio with T2D prevalence

 Mean (SD)

0.59 (0.20)

0.99 (0.10)

1.34 (0.10)

1.73 (0.16)

 Case/N

76/255

10/255

20/257

29/258

 Model 1

1

0.09 (0.05, 0.18)^**

0.20 (0.12, 0.35)^**

0.29 (0.18, 0.46)^**

 Model 2

1

0.15 (0.07, 0.33)^**

0.37 (0.20, 0.68)^**

0.60 (0.35, 1.02)

 Model 3

1

0.15 (0.07, 0.34)^**

0.37 (0.20, 0.68)^**

0.60 (0.35, 1.03)

 Mean (SD)

0.77 (0.14)

1.03 (0.06)

1.23 (0.06)

1.60 (0.25)

 Case/N

17/262

25/252

46/260

47/253

 Model 1

1

1.53 (0.80, 2.91)

2.91 (1.62, 5.24)^**

3.09 (1.71, 5.55)^**

 Model 2

1

1.68 (0.75, 3.79)

3.59 (1.72, 7.49)^**

3.52 (1.67, 7.41)^**

 Model 3

1

1.65 (0.73, 3.73)

3.49 (1.67, 7.31)^**

3.38 (1.60, 7.14)^**

 Mean (SD)

0.58 (0.08)

0.79 (0.07)

1.10 (0.13)

2.26 (0.95)

 Case/N

17/256

31/257

16/258

71/256

 Model 1

1

1.82 (0.98, 3.38)

0.84 (0.41, 1.71)

5.12 (2.91, 9.02)^**

 Model 2

1

1.56 (0.82, 2.97)

0.75 (0.36, 1.58)

2.53 (1.35, 4.73)^**

 Model 3

1

1.50 (0.78, 2.87)

0.72 (0.34, 1.52)

2.39 (1.27, 4.52)^*